|
|
| June 8, 2005: The Truth About Drug Eluting Stents: Clinical Restenosis, Stent Thrombosis, and Long-Term Anti-Ischemic Therapy after PC |
This video is sponsored by the Duke Clinical Medical Series.
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest speaker, Jeffrey J. Popma MD, has indicated that he receives research/grant
support from Cordis, Boston Scientific, Medtronic, Abbott Vascular and Guidant.
|
| |